ABOUT KANCEL

What is Kancel?

About Kancel

Kancel is a geography-based oncology clinical trial finder

About Kancel

To learn more about Kancel – who we are and what we do – watch our video.

Kancel was created to make it easy for patients and physicians to find clinical trials near them. Oftentimes, it can be challenging to know what clinical trials are open and recruiting, what tumor site they are focused on, how to enroll in them, and where they are taking place. Kancel aims to remove these barriers to participation in clinical trials by providing users with a searchable database of the oncology clinical trials taking place in their area – users simply enter their cancer type and geographical location to get started.Kancel has been operating since 2018 and has helped over 1800 people find hematology and medical oncology clinical trials relevant to their disease. We currently list trials taking place in Quebec, and will be expanding our database to trials across Canada soon.

Helpful Support

If you are having difficulty using Kancel or have found an issue with the site, we’re always here to help. Simply get in touch with us and we’ll quickly find a solution.

Frequent Updates

We are proud to provide a thorough and up to date clinical trial finder for our users. We update Kancel frequently so it reflects the latest ongoing clinical trials, and we remove trials that are no longer recruiting.

Responsive Design

Our user-friendly and intuitive website has been optimized for all devices, so you can use Kancel anytime, anywhere – on your desktop at home, on your phone during your commute, or while relaxing with
your tablet.

19251

New visitors every month

874

Clinical trials on the site

377

Laboratories

121

New trials every month

Kancel Team

Hématologue et oncologue médical

ABOUT KANCEL

Kancel was created to make it easy for patients and physicians to find clinical trials near them. Kancel has been operating since 2018 and has helped over 1800 people find hematology and medical oncology clinical trials relevant to their disease. We currently list trials taking place in Quebec, and will be expanding our database to trials across Canada soon.